US2004171157A1PendingUtilityA1

Recombinational cloning using nucleic acids having recombination sites

67
Assignee: INVITROGEN CORPPriority: Oct 24, 1997Filed: Apr 8, 2004Published: Sep 2, 2004
Est. expiryOct 24, 2017(expired)· nominal 20-yr term from priority
C12N 15/66C12N 15/10C12N 9/00C12N 15/64
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for cloning or subcloning one or more desired nucleic acid molecules comprising: 
 (a) combining in vitro or in vivo 
 (i) one or more Insert Donor molecules comprising one or more desired nucleic acid segments flanked by at least two recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 (ii) one or more Vector Donor molecules comprising at least two recombination sites, wherein said recombination sites do not substantially recombine with each other; and  
 (iii) one or more site-specific recombination proteins;  
   (b) incubating said combination under conditions sufficient to transfer one or more of said desired segments into one or more of said Vector Donor molecules, thereby producing one or more desired Product nucleic acid molecules;    (c) combining in vitro or in vivo 
 (i) one or more of said Product molecules comprising said desired segments flanked by two or more recombination sites, wherein said recombination sites do not substantially recombine with each other;  
 (ii) one or more different Vector Donor molecules comprising two or more recombination sites, wherein said recombination sites do not substantially recombine with each other; and  
 (iii) one or more site-specific recombination proteins; and  
   (d) incubating said combination under conditions sufficient to transfer one or more of said desired segments into one or more different Vector Donor molecules, thereby producing one or more different Product molecules.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.